De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells

Journal of Virology

Volumn 76, Issue 5, 2002, Pages 2440-2448

  Lagunoff, Michael ^a   Bechtel, Jill ^a   Venetsanakos, Eleni ^a   Roy, Anne Marie ^a   Abbey, Nancy ^a   Herndier, Brian ^a   McMahon, Martin ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHONOACETIC ACID; TELOMERASE; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL STRAIN; CELL STRUCTURE; CONTROLLED STUDY; CYTOLYSIS; CYTOPATHOGENIC EFFECT; DNA SYNTHESIS; ENDOTHELIUM CELL; GENETIC ANALYSIS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LATENT VIRUS INFECTION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; SUPERNATANT; TUMOR BIOPSY; VIRION; VIRUS CELL TRANSFORMATION; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

CAENORHABDITIS ELEGANS PROTEINS; CELL TRANSFORMATION, VIRAL; CYTOPATHOGENIC EFFECT, VIRAL; ENDOTHELIUM, VASCULAR; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MICROCIRCULATION; PHORBOL ESTERS; PLAQUE ASSAY; PROTEIN KINASE C; RECEPTORS, DRUG; SKIN; TELOMERASE; TUMOR CELLS, CULTURED; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0036171260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.76.5.2440-2448.2002     Document Type: Article

References (35)

1. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma
2. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
3. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant
4. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
5. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: Formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures
6. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells
7. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients
8. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma
9. AIDS-Kaposi's sarcoma derived cells express cytokines with autocrine and paracrine growth effect
10. Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
11. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
12. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma
13. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
14. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
15. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line
16. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: Effect of polyethylene glycol on adsorption and penetration
17. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals
18. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women
19. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus
20. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
21. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: Implications for KS pathogenesis
22. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
23. Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon
24. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein
25. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant
26. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection
27. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8
28. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen
29. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
30. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
31. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
32. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus
33. Induction by glioblastoma cells of tubulogenesis in telomerase-immortalized human microvascular endothelial cells
34. Human endothelial cell life extension by telomerase expression
35. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: Characterization of antiherpesvirus agents